To date, Biovista has profiled and screened 12 drugs with significant potential in Parkinson’s, Alzheimer’s, Epilepsy, Depression and Sleep Disorders. The company are in the process of filing for novel use patents for these drugs.

These drugs can be used either singly or in combination with other drugs, and we believe have significant promise in these hard to treat conditions.

To find out more about our program in CNS please contact us.